GW Research patents new cannabidiol-C4 derivatives for epilepsy

Dec. 2, 2022

No Comments

GW Research Ltd. has disclosed cannabidiol-C4 (CBD-C4) derivatives reported to be useful for...

BioWorld Science Neurology/psychiatric Patents

Today's news in brief

BioWorld

BioWorld briefs for Oct. 14, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for October 14, 2024.

Visualization of protein folding process

Protein design: if you can’t find ’em, make ’em

BioWorld

David Baker, director of the Institute for Protein Design at the University of Washington School of Medicine, is a pioneer in protein design. His contributions...

Gilead ends $785M Yuhan deal for small-molecule MASH drugs

BioWorld

Gilead Sciences Inc. terminated a potential $785 million licensing deal with Yuhan Corp. inked in 2019 to develop metabolic dysfunction-associated steatohepatitis...

FDA gives early nod to Genentech’s first-line breast cancer drug

BioWorld

Genentech Inc. didn’t need to wait until Thanksgiving for the U.S. FDA to make up its mind. More than a month ahead of its PDUFA date, the agency approved the...

Upgrade your daily dose of biopharma and medtech news

GW Research patents new cannabidiol-C4 derivatives for epilepsy